Post

New research · Ophthalmology
European journal of ophthalmology · 3d
Cohort studyEuropean journal of ophthalmology · 2026

Short-term intraocular pressure changes following intravitreal injections of aflibercept 8mg versus 2mg: A prospective comparative study.

Imran Karim Janmohamed, Saleh Sahbi, Arsam Mahmood … Luke Membrey
Read paper
OphthalmologyCohort study

Aflibercept 8mg produces intraocular pressure spikes similar to the 2mg dose after injection.

Short-term intraocular pressure changes following intravitreal injections of aflibercept 8mg versus 2mg: A prospective comparative study.

Imran Karim Janmohamed … Luke Membrey
European journal of ophthalmology · 2026
Purpose

This study evaluated acute IOP dynamics following aflibercept 8 mg compared to aflibercept 2 mg and identified predictive factors for pressure elevation.

Results

eye pressure spiked just as high right after injection with either dose

14mmHg
Before
39.3mmHg
After
More results

Both formulations produced significant IOP elevations from baseline at T1 and T2 ( p < 0.001 within each group).

No significant between-group differences were identified at any timepoint.

More results

Pre-existing glaucoma/OHT was the only consistent independent predictor of both IOP >21 mmHg (OR 3.00-3.31, p = 0.024-0.038) and IOP elevation >5 mmHg from baseline (OR 10.45-11.75, p < 0.001) at T2; aflibercept formulation was not associated with either outcome.

No injection required paracentesis.

“
Conclusion

Aflibercept 8 mg demonstrates comparable IOP dynamics to aflibercept 2 mg. Glaucoma/OHT represents the strongest predictor of early pressure elevation, warranting enhanced monitoring.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement
Cohort Study
86.7%
of infants probed after 12 months still had unresolved tear duct blockage
Observational
16%
eyelid tissue in rosacea patients showed less of this key repair-signaling protein inside cell nuclei
Cohort Study
25%
about 1 in 4 treated cases had symptoms return after improving